D-galactosamine-induced mouse hepatic apoptosis: Possible involvement with tumor necrosis factor, but not with caspase-3 activity

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 10, 1999, Pages 1127-1130

  Itokazu, Yoshihiko ^a   Segawa, Yoshihide ^a   Inoue, Naonori ^a   Omata, Takeshi ^a  

^a ZERIA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Apoptosis; D galactosamine induced hepatotoxicity; Liver caspase 3 activity; Liver DNA fragmentation; Liver TNF mRNA

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; DNA FRAGMENT; GALACTOSAMINE; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIVER CELL; LIVER TOXICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0032708145     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.1127     Document Type: Article

References (19)

1. Schlegel J., Peters I., Orrenius S., Miller D. K., Thornberry N. A., Yamin T. T., Nicholson D. W., J. Biol. Chem., 26, 1841-1844 (1996).
2. Rodriguez I., Matsuura K., Ody C., Nagata S., Vassalli P., J. Exp. Med., 184, 2067-2072 (1996).
3. Jaeschke H., Fisher M. A., Lawson J. A., Simmons C. A., Farhood A., Jones D. A., J. Immunol., 160, 3480-3486 (1998).
4. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S., Nature (London), 364, 806-809 (1993).
5. Gantner F., Leist M., Lohse A. W., Germann P. G., Tiegs G., Hepatology, 21, 190-198 (1995).
6. Trautwein C., Rakemann T., Brenner D. A., Streetz K., Licato L., Manns M. P., Tiegs G., Gastroenterol., 114, 1035-1045 (1998).
7. Nagakawa J., Hishinuma I., Hirota K., Miyamoto K., Yamanaka T., Tsukidate K., Katayama K., Yamatsu I., Gastroenterol., 99, 758-765 (1990).
8. Tsutsui S., Hirasawa K., Takeda M., Itagaki S., Kawamura S., Maeda K., Mikami T., Doi K., J. Vet. Med. Sci., 59, 785-790 (1997).
9. Tsutsui S., Hirasawa K., Takeda M., Itagaki S., Kawamura S., Maeda K., Mikami T., Doi K., Exp. Toxic. Pathol., 49, 301-306 (1997).
10. Chomczynski P., Sacchi N., Anal. Biochem., 162, 156-159 (1987).
11. Stachlewitz R. F., Seabra V., Bradford B., Bradham C. A., Rusyn I., Germolec D., Thurman R. G., Hepatology, 29, 737-745 (1999).
12. Okamoto T., Kobayashi T., Jpn. J. Pharmacol., 75, 199-201 (1997).
13. Kusters S., Gantner F., Kunstle G., Tiegs G., Gastroenterol., 111, 462-471 (1996).
14. Mizuhara H., Kuno M., Seki N., Yu W. G., Yamaoka M., Yamashita M., Ogawa T., Kanada K., Fujii T., Senoh H., Fujiwara H., Hepatology, 27, 513-519 (1998).
15. Verheij M., Bose R., Lin X. H., Yao B., Jarvis W. D., Grant S., Birrer M. J., Szabo E., Zon L. I., Kyriakis J. M., Haimovitz-Friedman A., Fuks Z., Kolesnick R. N., Nature (London), 380, 75-79 (1996).
16. Woo K. R., Shu W. P., Kong L., Liu B. C., J. Urol., 155, 1779-1783 (1996).
17. Ray S. D., Kamendulis L. M., Gurule M. W., Yorkin R. D., Corcoran G. B., FASEB J., 7, 453-463 (1993).
18. Ray S. D., Mumaw V. R., Raje R. R., Fariss M. W., J. Pharmacol. Exp. Ther., 279, 1470-1483 (1996).
19. Ray S. D., Sorge C. L., Kamendulis L. M., Corcoran G. B., J. Pharmacol. Exp. Ther., 263, 387-394 (1992).